Michael D. Clayman

2014

In 2014, Michael D. Clayman earned a total compensation of $2.9M as President, CEO and Co-Founder at Flexion Therapeutics.

Compensation breakdown

Bonus$225,102
Option Awards$2,149,718
Salary$450,204
Other$32,357
Total$2,857,381

Clayman received $2.1M in option awards, accounting for 75% of the total pay in 2014.

Clayman also received $225.1K in bonus, $450.2K in salary and $32.4K in other compensation.

Rankings

In 2014, Michael D. Clayman's compensation ranked 3,187th out of 13,032 executives tracked by ExecPay. In other words, Clayman earned more than 75.5% of executives.

ClassificationRankingPercentile
All
3,187
out of 13,032
76th
Division
Manufacturing
1,133
out of 4,966
77th
Major group
Chemicals And Allied Products
363
out of 1,686
79th
Industry group
Drugs
285
out of 1,365
79th
Industry
Pharmaceutical Preparations
233
out of 1,043
78th
Source: SEC filing on April 26, 2016.

Clayman's colleagues

We found two more compensation records of executives who worked with Michael D. Clayman at Flexion Therapeutics in 2014.

2014

Neil Bodick

Flexion Therapeutics

Chief Marketing Officer

2014

Frederick Driscoll

Flexion Therapeutics

Chief Financial Officer

News

In-depth

You may also like